Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1997 Dec;61(6):1293–1302. doi: 10.1086/301633

Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.

L B Jacoby 1, D Jones 1, K Davis 1, D Kronn 1, M P Short 1, J Gusella 1, M MacCollin 1
PMCID: PMC1716092  PMID: 9399891

Abstract

Patients with multiple schwannomas without vestibular schwannomas have been postulated to compose a distinct subclass of neurofibromatosis (NF), termed "schwannomatosis." To compare the molecular-genetic basis of schwannomatosis with NF2, we examined the NF2 locus in 20 unrelated schwannomatosis patients and their affected relatives. Tumors from these patients frequently harbored typical truncating mutations of the NF2 gene and loss of heterozygosity of the surrounding region of chromosome 22. Surprisingly, unlike patients with NF2, no heterozygous NF2-gene changes were seen in normal tissues. Examination of multiple tumors from the same patient revealed that some schwannomatosis patients are somatic mosaics for NF2-gene changes. By contrast, other individuals, particularly those with a positive family history, appear to have an inherited predisposition to formation of tumors that carry somatic alterations of the NF2 gene. Further work is needed to define the pathogenetics of this unusual disease mechanism.

Full text

PDF

Images in this article

1296Figure 1
on p.1296

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson M. A., Gusella J. F. Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro. 1984 Nov;20(11):856–858. doi: 10.1007/BF02619631. [DOI] [PubMed] [Google Scholar]
  2. Arpin M., Algrain M., Louvard D. Membrane-actin microfilament connections: an increasing diversity of players related to band 4.1. Curr Opin Cell Biol. 1994 Feb;6(1):136–141. doi: 10.1016/0955-0674(94)90127-9. [DOI] [PubMed] [Google Scholar]
  3. Berger T. G., Lapins N. A., Engel M. L. Agminated neurilemomas. J Am Acad Dermatol. 1987 Nov;17(5 Pt 2):891–894. doi: 10.1016/s0190-9622(87)70276-x. [DOI] [PubMed] [Google Scholar]
  4. Bijlsma E. K., Merel P., Bosch D. A., Westerveld A., Delattre O., Thomas G., Hulsebos T. J. Analysis of mutations in the SCH gene in schwannomas. Genes Chromosomes Cancer. 1994 Sep;11(1):7–14. doi: 10.1002/gcc.2870110103. [DOI] [PubMed] [Google Scholar]
  5. Bourn D., Strachan T. Highly polymorphic dinucleotide repeat at the NF2 gene. Hum Genet. 1995 Jun;95(6):712–712. doi: 10.1007/BF00209494. [DOI] [PubMed] [Google Scholar]
  6. Bouzas E. A., Parry D. M., Eldridge R., Kaiser-Kupfer M. I. Visual impairment in patients with neurofibromatosis 2. Neurology. 1993 Mar;43(3 Pt 1):622–623. doi: 10.1212/wnl.43.3_part_1.622. [DOI] [PubMed] [Google Scholar]
  7. Buenger K. M., Porter N. C., Dozier S. E., Wagner R. F., Jr Localized multiple neurilemmomas of the lower extremity. Cutis. 1993 Jan;51(1):36–38. [PubMed] [Google Scholar]
  8. Evans D. G., Huson S. M., Donnai D., Neary W., Blair V., Newton V., Harris R. A clinical study of type 2 neurofibromatosis. Q J Med. 1992 Aug;84(304):603–618. [PubMed] [Google Scholar]
  9. Evans D. G., Mason S., Huson S. M., Ponder M., Harding A. E., Strachan T. Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study. J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):361–366. doi: 10.1136/jnnp.62.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gonzalez-Agosti C., Xu L., Pinney D., Beauchamp R., Hobbs W., Gusella J., Ramesh V. The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene. 1996 Sep 19;13(6):1239–1247. [PubMed] [Google Scholar]
  11. Gutmann D. H., Aylsworth A., Carey J. C., Korf B., Marks J., Pyeritz R. E., Rubenstein A., Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997 Jul 2;278(1):51–57. [PubMed] [Google Scholar]
  12. Honda M., Arai E., Sawada S., Ohta A., Niimura M. Neurofibromatosis 2 and neurilemmomatosis gene are identical. J Invest Dermatol. 1995 Jan;104(1):74–77. doi: 10.1111/1523-1747.ep12613537. [DOI] [PubMed] [Google Scholar]
  13. Jacoby L. B., MacCollin M., Barone R., Ramesh V., Gusella J. F. Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer. 1996 Sep;17(1):45–55. doi: 10.1002/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  14. Jacoby L. B., MacCollin M., Louis D. N., Mohney T., Rubio M. P., Pulaski K., Trofatter J. A., Kley N., Seizinger B., Ramesh V. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet. 1994 Mar;3(3):413–419. doi: 10.1093/hmg/3.3.413. [DOI] [PubMed] [Google Scholar]
  15. Kaiser-Kupfer M. I., Freidlin V., Datiles M. B., Edwards P. A., Sherman J. L., Parry D., McCain L. M., Eldridge R. The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol. 1989 Apr;107(4):541–544. doi: 10.1001/archopht.1989.01070010555030. [DOI] [PubMed] [Google Scholar]
  16. Lewis R. C., Jr, Nannini L. H., Cocke W. M., Jr Multifocal neurilemmomas of median and ulnar nerves of the same extremity--case report. J Hand Surg Am. 1981 Jul;6(4):406–408. doi: 10.1016/s0363-5023(81)80054-8. [DOI] [PubMed] [Google Scholar]
  17. MacCollin M., Ramesh V., Jacoby L. B., Louis D. N., Rubio M. P., Pulaski K., Trofatter J. A., Short M. P., Bove C., Eldridge R. Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet. 1994 Aug;55(2):314–320. [PMC free article] [PubMed] [Google Scholar]
  18. MacCollin M., Woodfin W., Kronn D., Short M. P. Schwannomatosis: a clinical and pathologic study. Neurology. 1996 Apr;46(4):1072–1079. doi: 10.1212/wnl.46.4.1072. [DOI] [PubMed] [Google Scholar]
  19. Marineau C., Baron C., Delattre O., Zucman J., Thomas G., Rouleau G. A. Dinucleotide repeat polymorphism at the D22S268 locus. Hum Mol Genet. 1993 Mar;2(3):336–336. doi: 10.1093/hmg/2.3.336-a. [DOI] [PubMed] [Google Scholar]
  20. Mautner V. F., Tatagiba M., Guthoff R., Samii M., Pulst S. M. Neurofibromatosis 2 in the pediatric age group. Neurosurgery. 1993 Jul;33(1):92–96. doi: 10.1227/00006123-199307000-00014. [DOI] [PubMed] [Google Scholar]
  21. Parry D. M., Eldridge R., Kaiser-Kupfer M. I., Bouzas E. A., Pikus A., Patronas N. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet. 1994 Oct 1;52(4):450–461. doi: 10.1002/ajmg.1320520411. [DOI] [PubMed] [Google Scholar]
  22. Parry D. M., MacCollin M. M., Kaiser-Kupfer M. I., Pulaski K., Nicholson H. S., Bolesta M., Eldridge R., Gusella J. F. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet. 1996 Sep;59(3):529–539. [PMC free article] [PubMed] [Google Scholar]
  23. Pulst S. M., Riccardi V., Mautner V. Spinal schwannomatosis. Neurology. 1997 Mar;48(3):787–788. doi: 10.1212/wnl.48.3.787. [DOI] [PubMed] [Google Scholar]
  24. Purcell S. M., Dixon S. L. Schwannomatosis. An unusual variant of neurofibromatosis or a distinct clinical entity? Arch Dermatol. 1989 Mar;125(3):390–393. doi: 10.1001/archderm.125.3.390. [DOI] [PubMed] [Google Scholar]
  25. Ragge N. K., Baser M. E., Klein J., Nechiporuk A., Sainz J., Pulst S. M., Riccardi V. M. Ocular abnormalities in neurofibromatosis 2. Am J Ophthalmol. 1995 Nov;120(5):634–641. doi: 10.1016/s0002-9394(14)72210-x. [DOI] [PubMed] [Google Scholar]
  26. Rouleau G. A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993 Jun 10;363(6429):515–521. doi: 10.1038/363515a0. [DOI] [PubMed] [Google Scholar]
  27. Ruttledge M. H., Andermann A. A., Phelan C. M., Claudio J. O., Han F. Y., Chretien N., Rangaratnam S., MacCollin M., Short P., Parry D. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet. 1996 Aug;59(2):331–342. [PMC free article] [PubMed] [Google Scholar]
  28. Sainz J., Nechiporuk A., Kim U. J., Simon M. I., Pulst S. M. CA-repeat polymorphism at the D22S430 locus adjacent to NF2. Hum Mol Genet. 1993 Dec;2(12):2203–2203. doi: 10.1093/hmg/2.12.2203. [DOI] [PubMed] [Google Scholar]
  29. Sasaki T., Nakajima H. Congenital neurilemmomatosis. J Am Acad Dermatol. 1992 May;26(5 Pt 1):786–787. doi: 10.1016/s0190-9622(08)80565-8. [DOI] [PubMed] [Google Scholar]
  30. Shishiba T., Niimura M., Ohtsuka F., Tsuru N. Multiple cutaneous neurilemmomas as a skin manifestation of neurilemmomatosis. J Am Acad Dermatol. 1984 May;10(5 Pt 1):744–754. doi: 10.1016/s0190-9622(84)70089-2. [DOI] [PubMed] [Google Scholar]
  31. Stangl A. P., Wellenreuther R., Lenartz D., Kraus J. A., Menon A. G., Schramm J., Wiestler O. D., von Deimling A. Clonality of multiple meningiomas. J Neurosurg. 1997 May;86(5):853–858. doi: 10.3171/jns.1997.86.5.0853. [DOI] [PubMed] [Google Scholar]
  32. Trofatter J. A., MacCollin M. M., Rutter J. L., Murrell J. R., Duyao M. P., Parry D. M., Eldridge R., Kley N., Menon A. G., Pulaski K. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993 Mar 12;72(5):791–800. doi: 10.1016/0092-8674(93)90406-g. [DOI] [PubMed] [Google Scholar]
  33. Weissenbach J., Gyapay G., Dib C., Vignal A., Morissette J., Millasseau P., Vaysseix G., Lathrop M. A second-generation linkage map of the human genome. Nature. 1992 Oct 29;359(6398):794–801. doi: 10.1038/359794a0. [DOI] [PubMed] [Google Scholar]
  34. Wellenreuther R., Kraus J. A., Lenartz D., Menon A. G., Schramm J., Louis D. N., Ramesh V., Gusella J. F., Wiestler O. D., von Deimling A. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol. 1995 Apr;146(4):827–832. [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES